Prolonged effect of succinylcholine after neostigmine and pyridostigmine administration in patients with renal failure.
D000328:Adult; D000768:Anesthesia, General; D002091:Butyrylcholinesterase / Q000097:blood; D002800:Cholinesterase Inhibitors; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D016030:Kidney Transplantation; D008297:Male; D009388:Neostigmine / Q000494:pharmacology*; D011729:Pyridostigmine Bromide / Q000494:pharmacology*; D013390:Succinylcholine / Q000378:metabolism / Q000494:pharmacology*; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D002091:Butyrylcholinesterase; D013390:Succinylcholine; D011729:Pyridostigmine Bromide